Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells
In conclusion, in this study, we demonstrated how the combination of β-LP and HT could offer an affordable, safe, and effective approach against TNBC.PMID:38518601 | DOI:10.1016/j.biopha.2024.116439
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Jes ús Calahorra Jos é L Blaya-Cánovas Olivia Castellini-P érez Ernesto Aparicio-Puerta Candela Cives-Losada Jose J G Marin Markel Rementeria Francisca E Cara Araceli L ópez-Tejada Carmen Gri ñán-Lisón Francesco Aulicino Imre Berger Juan A Marchal Source Type: research
More News: Antidoxidants | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Drugs & Pharmacology | Stem Cell Therapy | Stem Cells | Study | Taxotere